MedTrace Logo

Systemic Lupus Erythematosus (SLE) Prospective Observational Cohort Study (SPOCS)

NCT03189875 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 830

Last updated 2024-02-28

No results posted yet for this study

Summary

SPOCS is an international, multicenter, prospective observational cohort study with bi-annual study visits over a 3-year follow-up designed to systematically describe the comprehensive SLE patient-journey regarding clinical features, disease progression and treatment patterns, SLE outcomes, health status assessments (PROs), and health care resource utilization (HCRU) in a general population of moderate-to-severe SLE patients.

Conditions

Interventions

OTHER

Standard of Care

Participants will be followed as per local routine clinical practice

Sponsors & Collaborators

Eligibility

Min Age
18 Years
Max Age
130 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-28
Primary Completion
2022-11-18
Completion
2022-11-18

Countries

  • United States
  • Australia
  • Canada
  • France
  • Germany
  • Italy
  • Spain
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03189875 on ClinicalTrials.gov